Caribou Bio was founded in 2011 by Jennifer Doudna, Rachel Haurwitz, Martin Jinek and James Berger. The core technologies were born out of research carried out in the Doudna Lab at the University of California, Berkeley. Key research programs at Caribou focus on further development of Cas9 and CRISPR technologies with improved genome engineering activity. Our mission is to enable any genome to be modified at any site in any way.
Caribou Bio forms strategic alliances with companies in the research, therapeutics, agriculture, and industrial bio fields. We provide our partners and customers with technology-based solutions for new and improved products. For further information about solutions we can provide for your company.